Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD
Thorax Jun 22, 2018
Charususin N, et al. - In this double-blind, multicentre randomised controlled trial, researchers tested adjunctive inspiratory muscle training (IMT) for its ability to enhance the well-established benefits of pulmonary rehabilitation (PR) in patients with COPD. They randomised COPD patients (FEV1: 42%±16% predicted) with inspiratory muscle weakness (PImax: 51±15 cm H2O) into an intervention group (IMT+PR; n=110) or a control group (Sham-IMT+PR; n=109). They observed that adjunctive IMT did lead to improvements in respiratory muscle function but these improvements did not translate into additional improvements in 6 min walking distance. Other outcomes observed in the intervention group included additional gains in endurance time and reductions in symptoms of dyspnoea during an endurance cycling test.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries